Armand Bensussan

Armand Bensussan completed his PhD training during the early 1980s in the laboratory of the Nobel Prize in physiology or medicine Professor Jean Dausset (Saint-Louis Hospital, Paris, France) and in de department of Professor Stuart F Schlossman (Harvard Medical School, DFCI, Boston, MA). He was Director of Research Exceptional Class at INSERM and past chief of the Skin Research Center and of the INSERM unit 976 at Saint-Louis Hospital in Paris, France. He is now Emeritus Research Director at INSERM Unit 1342, Saint-Louis Hospital in Paris, France. He obtained several awards including two distinct French Academy of Sciences awards, the clinical investigation award from the French foundation for medical research, the immunology Bernard Halpern award, the national award of projects leaders for the creation and/or the development of highly innovative technology companies and Galien award. He was the past president of the French society of immunology. He is the co-founder of the biotechnology companies including Orega Biotech (www.orega-biotech.com), Alderaan Biotechnology, Cabestelle Biopharma. His main scientific contributions have been in the field of basic and clinical immunology and in tumor dermatology. He is author of more than 370 international scientific publications, co-inventor in more than 50 patents and editor of two scientific books. He is a member of the Human Cell Differentiation Molecules council (http://www.hcdm.org) and of the EuroMAbNet council (http://www.euromabnet.com).